0
HUTCHMED Banner Image

HUTCHMED

  • Ticker HCM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
HUTCHMED Logo Image
  • 1001-5000 Employees
  • Based in Central, Hong Kong
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. A dedicated organization of over 1,300 personnel has advanced ten cancer drug candidates from in-house discovery intoMore clinical studies around the world, with its first three oncology drugs now approved and launched.
HUTCHMED

Most Recent Responsibility Report

HUTCHMED
MOST RECENT 2023 Sustainability Report

HUTCHMED does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived HUTCHMED Sustainability Report, HUTCHMED Corporate Social Responsibility Report, HUTCHMED CSR Report, HUTCHMED Corporate Responsibility, HUTCHMED CR Report, HUTCHMED Citizenship Report, HUTCHMED ESG Report, and HUTCHMED Environmental Report online.
HUTCHMED Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!